Impact of opioid use disorder as a safety risk in elective total hip arthroplasty: an imperative for routine preoperative screening

Patient Safety in Surgery · Published 2025-12-20 · DOI 10.1186/s13037-025-00469-5

Free full text

Authors being retrieved — see the publisher record. https://doi.org/10.1186/s13037-025-00469-5

Abstract

Abstract Background Total hip arthroplasty (THA) utilization is rising worldwide, but the concurrent opioid epidemic has introduced new perioperative safety challenges. Opioid use disorder (OUD) is a chronic relapsing condition that may complicate surgical management and increase preventable adverse events. Methods During the study period from January 1, 2016 to December 31, 2022, a total of 1,957,284 elective primary THA cases were identified in the National Inpatient Sample. Of these, 12,285 (0.6%) had a documented diagnosis of opioid use disorder (OUD). After 1:1 propensity score matching, 12,285 OUD cases were matched to 12,285 non-OUD controls with comparable baseline characteristics. Results Patients with OUD had significantly longer mean length of stay (p < 0.001), higher hospital charges (approximately 15% higher, p < 0.001), and increased rates of in-hospital postoperative complications compared with matched controls. Conclusions Patients with OUD undergoing THA experience significantly worse inpatient outcomes and higher costs. These findings highlight OUD as a modifiable surgical-safety risk factor and support the implementation of routine preoperative OUD screening and optimization protocols to improve patient safety and resource utilization.

Abstract from DOAJ. Public domain (CC0 1.0).

Read the article at the publisher →

Publication details

Year
2025

Related articles